Guess which ASX 200 stock's founders just sold $176m of shares

Should you be concerned by this insider selling?

| More on:
Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As I mentioned here yesterday, insider selling is often regarded as a bearish indicator.

That's because if insiders believed that their shares were undervalued and destined to rise, they wouldn't part ways with them.

So, should owners of Pro Medicus Limited (ASX: PME) shares be concerned that their founders have just sold down their holdings?

What's happening?

According to an announcement, the ASX 200 stock's co-founders, Dr Sam Hupert and Anthony Hall, have each sold 1 million Pro Medicus shares during the current trading window.

Dr Hupert and Hall received an average of $88.02 per share, which equates to a total consideration of approximately $88 million each or $176 million combined.

The good news for shareholders is that demand for these shares was evidently very strong because the sale was undertaken at market price and represents only a 1.5% discount to the ASX 200 stock's record high.

As a comparison, the beleaguered tech stock Appen Ltd (ASX: APX) is currently attempting to raise $30 million from investors at a whopping 42.1% discount to its last close price.

Why are they selling this ASX 200 stock?

The company explained that the sale was made after the founders were approached by an individual fund. It said:

The Pro Medicus Board has been advised that co-founders Dr Sam Hupert and Mr Anthony Hall have sold 1 million shares each in the current trading window representing less than 4% of their individual holdings. The sale was in response to a strong approach from an individual fund and was done before market at the previous day's closing price (0% discount).

Should you be concerned?

While insider selling doesn't usually go down well with the market, it is important to put things into perspective.

Firstly, the company notes that the two founders remain "actively engaged in the company as executives and board members and are committed to its future."

Furthermore, "they remain the two key stake holders in the company with their combined holding post this recent sale of 48%." Clearly their interests remain firmly aligned with shareholders.

It is also worth highlighting that both founders have "re-affirmed that they do not intend to sell any further shares in PME in the foreseeable future."

This ASX 200 stock is up more than 50% over the last 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Appen and Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A man with grahpics of robot arms, indicating a share price movement in ASX robotics and tech companies
Share Market News

Here's how the ASX 200 market sectors stacked up this week

Tech shares led the pack for a second week, clocking a near 10% gain over the fortnight.

Read more »

Three smiling corporate people examine a model of a new building complex.
Earnings Results

Pexa share price jumps on 'strong' half-year result

This property technology company's shares are ending the week on a high.

Read more »

A man with a beard and wearing dark sunglasses and a beanie head covering raises a fist in happy celebration as he sits at is computer in a home environment.
Technology Shares

RPMGlobal share price up 9% amid tech stock rally

Tech stocks are leading the market today following a NASDAQ surge overnight.

Read more »

A woman holds her hand out under a graphic hologram image of a human brain with brightly lit segments and section points.
Share Gainers

The Brainchip share price is up 213% this month. Is Nvidia to blame?

The small cap Aussie tech stock is going bananas in 2024.

Read more »

women with a microphone is happy whilst using a computer
Technology Shares

Why are ASX tech shares booming on Friday?

ASX tech shares are currently leading the entire stock market.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Technology Shares

Own Life360 shares? Here's your FY23 results preview

This tech stock will be releasing its results next week. What is the market expecting?

Read more »

Group image of Aussie Broadband leaders Michael Omeros, Phillip Britt and Brian Maher.
Earnings Results

Aussie Broadband share price rockets 11% after bumper results and upgraded guidance

The premium internet services provider also announced leadership changes.

Read more »

rising asx share price represented by drone flying in the air
Technology Shares

How has the DroneShield share price gained 90% in a month?

DroneShield shares are once again at a new record high today.

Read more »